222 related articles for article (PubMed ID: 32425818)
1. Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders.
Westwell-Roper C; Stewart SE
Front Psychiatry; 2020; 11():264. PubMed ID: 32425818
[No Abstract] [Full Text] [Related]
2. Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders.
Sethi R; Gómez-Coronado N; Walker AJ; Robertson OD; Agustini B; Berk M; Dodd S
Front Psychiatry; 2019; 10():605. PubMed ID: 31551825
[TBL] [Abstract][Full Text] [Related]
3. [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].
Stichtenoth DO; Zeidler H; Frölich JC
Med Klin (Munich); 1998 Jul; 93(7):407-15. PubMed ID: 9711054
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders.
Perrone MG; Centonze A; Miciaccia M; Ferorelli S; Scilimati A
Molecules; 2020 Nov; 25(22):. PubMed ID: 33217958
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation.
Tang SW; Helmeste D; Leonard B
Acta Neuropsychiatr; 2021 Aug; 33(4):165-177. PubMed ID: 33926589
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of pediatric acute-onset neuropsychiatric syndrome (PANS) in children and adolescents with eating disorders.
Aman M; Coelho JS; Lin B; Lu C; Westwell-Roper C; Best JR; Stewart SE
J Eat Disord; 2022 Dec; 10(1):194. PubMed ID: 36514161
[TBL] [Abstract][Full Text] [Related]
7. Obsessive-compulsive disorder.
Drubach DA
Continuum (Minneap Minn); 2015 Jun; 21(3 Behavioral Neurology and Neuropsychiatry):783-8. PubMed ID: 26039854
[TBL] [Abstract][Full Text] [Related]
8. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
Longo WE; Panesar N; Mazuski J; Kaminski DL
Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):325-39. PubMed ID: 9990676
[TBL] [Abstract][Full Text] [Related]
9. Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs.
Pairet M; van Ryn J
Inflamm Res; 1998 Oct; 47 Suppl 2():S93-101. PubMed ID: 9831330
[TBL] [Abstract][Full Text] [Related]
10. Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.
Hétu PO; Riendeau D
Biochem J; 2005 Nov; 391(Pt 3):561-6. PubMed ID: 16008526
[TBL] [Abstract][Full Text] [Related]
11. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
[TBL] [Abstract][Full Text] [Related]
12. Druggable Prostanoid Pathway.
Mazaleuskaya LL; Ricciotti E
Adv Exp Med Biol; 2020; 1274():29-54. PubMed ID: 32894506
[TBL] [Abstract][Full Text] [Related]
13. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review.
Cruz JV; Rosa JMC; Kimani NM; Giuliatti S; Dos Santos CBR
Curr Med Chem; 2022; 29(17):3028-3049. PubMed ID: 34514981
[TBL] [Abstract][Full Text] [Related]
14. Catatonia in obsessive compulsive disorder.
Jagadheesan K; Nizamie HS; Thakur A
Indian J Psychiatry; 2002 Apr; 44(2):179-82. PubMed ID: 21206567
[TBL] [Abstract][Full Text] [Related]
15. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
[TBL] [Abstract][Full Text] [Related]
16. A Survey of Demographics, Symptom Course, Family History, and Barriers to Treatment in Children with Pediatric Acute-Onset Neuropsychiatric Disorders and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections.
O'Dor SL; Homayoun S; Downer OM; Hamel MA; Zagaroli JS; Williams KA
J Child Adolesc Psychopharmacol; 2022 Nov; 32(9):476-487. PubMed ID: 36383096
[No Abstract] [Full Text] [Related]
17. Synergy between cyclo-oxygenase-2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal antiinflammatory drug efficacy.
Hamilton LC; Mitchell JA; Tomlinson AM; Warner TD
FASEB J; 1999 Feb; 13(2):245-51. PubMed ID: 9973312
[TBL] [Abstract][Full Text] [Related]
18. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib.
Urdaneta A; Siso A; Urdaneta B; Cardenas R; Quintero L; Avila R; Suarez-Roca H
Brain Res Bull; 2009 Aug; 80(1-2):56-61. PubMed ID: 19463915
[TBL] [Abstract][Full Text] [Related]
20. Patient Satisfaction and Treatments Offered to Swedish Patients with Suspected Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
Hesselmark E; Bejerot S
J Child Adolesc Psychopharmacol; 2019 Oct; 29(8):634-641. PubMed ID: 31009235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
